Anheuser-Busch InBev is the largest brewer in the world and one of the top five consumer product companies by EBITDA... Show more
Anheuser-Busch InBev's American Depositary Receipts have staged a steady recovery after a late-September decline. The shares pulled back from around $79 in early September to a low near $73 in the opening days of October before climbing back toward the mid-$80s. This roughly 9% advance over the trailing 30 days has lifted the stock back above its short- and long-term moving averages and toward the upper end of its recent trading range.
Momentum has been supported by defensive demand for consumer staples, ongoing share repurchases, and renewed analyst coverage. The stock trades with a relatively low beta, reflecting its status as a large-cap defensive holding, while its dividend and buyback program continue to attract income- and value-oriented investors.
Anheuser-Busch InBev SA/NV is the world's largest brewer, headquartered in Leuven, Belgium, with American Depositary Receipts listed on the New York Stock Exchange under the ticker BUD. The company produces, markets, and distributes a portfolio of approximately 500 beer and beverage brands, including global flagships such as Budweiser, Bud Light, Corona, Stella Artois, and Michelob Ultra, alongside regional labels like Modelo Especial, Beck's, Hoegaarden, and Leffe.
The company operates across North America, Central and South America, Europe, the Middle East, Africa, and Asia-Pacific, giving it a diversified footprint spanning both mature and emerging markets. Its competitive strengths include unmatched global scale, premium and super-premium brand equity, a growing "Beyond Beer" portfolio spanning ready-to-drink beverages and spirits, and a digital B2B distribution platform called BEES. Investors follow the stock for its combination of defensive cash generation, a sizable dividend, and long-running share buyback program.
Several verified developments have shaped sentiment over the past month. The company's second-quarter results, reported in late July, exceeded expectations, with earnings of $1.21 per share against a $1.09 consensus and revenue of $16.66 billion, up 11% year over year. That beat provided a foundation for the stock's performance heading into the autumn.
At its 2026 Capital Markets Day, management unveiled the "Reignite" strategy, committing to concentrate investment on roughly 50 core brands from a portfolio of about 500, target 4%–8% annual organic EBITDA growth, and expand its BEES platform and AI-driven logistics tools. The brewer also continues to execute its share buyback program, repurchasing more than a million shares in the period spanning late September through early October.
Analyst activity has been mixed but broadly constructive. Wells Fargo reaffirmed a Buy rating in early October while trimming its price target to $88, and TD Cowen maintained a Hold rating while lowering its target to $85. Jefferies and Bank of America maintained or reiterated favorable views, while some firms flagged weaker alcohol volumes through the summer and cautious third-quarter volume expectations as the primary headwind.
In parallel, the company announced a $23 million investment in its Fort Collins, Colorado facility to expand Michelob Ultra production and launched a global "Choose Moderation" campaign showcasing its growing no- and low-alcohol portfolio.
Tickeron's Trending AI Robots page highlights a curated selection of the platform's top-performing AI trading bots. Tickeron offers hundreds of automated trading bots that trade thousands of tickers, but only the most relevant and best-performing systems appear in this featured section. The bots vary widely in strategy, timeframe, and performance metrics, giving traders a range of approaches to review. The page provides a concise way to compare how different AI-driven systems are positioning across the market. Traders interested in automated strategies can explore the section to identify bots aligned with their own objectives and risk tolerance.
Looking ahead, the most immediate catalyst is AB InBev's third-quarter 2026 earnings report, scheduled for October 29, 2026, with consensus estimates near $1.02 in earnings per share and $14.15 billion in revenue. Investors will focus on volume trends, particularly in the United States and Asia-Pacific, where analysts have flagged weaker demand, as well as pricing, premiumization, and margin performance.
Beyond the quarter, key themes include the rollout of the "Reignite" strategy, progress toward the company's medium-term EBIT growth targets, and the expansion of Beyond Beer and no-alcohol categories. Macroeconomic factors such as consumer spending, currency movements, and emerging-market demand will also influence results, while the pace of share buybacks and any changes to capital returns remain closely watched. Investors should monitor earnings, guidance updates, and analyst revisions rather than relying on short-term price moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BUD moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend. In 32 of 49 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 65%.
The 10-day RSI Indicator for BUD moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 16 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BUD as a result. In 36 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.
The Moving Average Convergence Divergence Histogram (MACD) for BUD turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 22 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for BUD crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 33%.
Following a +2.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in 184 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
BUD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 128 of 263 cases where BUD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.
The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.768) is normal, around the industry mean (1.331). BUD has a moderately high P/E Ratio (17.751) as compared to the industry average of (-0.154). Projected Growth (PEG Ratio) (1.583) is also within normal values, averaging (2.082). Dividend Yield (0.017) settles around the average of (0.037) among similar stocks. BUD's P/S Ratio (2.564) is slightly higher than the industry average of (1.539).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages
Industry FoodMeatFishDairy